Transpara for Women

Our mission: earlier detection for every woman

ScreenPoint's objective is to increase the number of women who can survive breast cancer.

Our two founders understood that the number of women being diagnosed with breast cancer was increasing worldwide. picture

Our two founders understood that the number of women being diagnosed with breast cancer was increasing worldwide.

But at the same time the number of specialist radiologists, who read every breast scan, was and is falling and the workload of those who are left is increasing.

This can lead to delays in getting results, unnecessary treatments and, understandably, very anxious patients. This is why we have developed Transpara, a system that reads breast scans and identifies potential cancers, more quickly than before.

The Transpara Exam Score

Transpara gives every scan an exam score, the higher the score, the higher the risk of a cancer in the mammogram.   picture

Transpara gives every scan an exam score, the higher the score, the higher the risk of a cancer in the mammogram.

Radiologists can then concentrate on reading mammograms that are more likely to have cancer, and when needed, arrange fast track treatment that gives each patient a higher chance of a cure.

How does it work?

Using the very latest developments in Artificial Intelligence called Deep Learning, Transpara has analysed millions of scans and ‘learned’ how to identify cancers both quickly and at an early stage. Transpara investigates a scan automatically and gives a radiologist a score from one to ten – The higher the number, the higher the risk of mammographic cancer.


Speed and Accuracy

The system reads a scan quickly and is proven to match the accuracy of an experienced radiologist. It enables the clinician to focus on the women who need further and fast investigation.


Reduces unnecessary treatment

There has been criticism that too many women have received unnecessary, painful treatment and anxiety. Transpara can help to avoid this happening and allow many patients to get back to normal quickly.


Real clinical benefits

Transpara is now in use in around 20 countries and an increasing number of academic reviews have shown it brings real clinical benefits. You can see some of these elsewhere on this site. 


The Future

Transpara is now a world leading system of its kind. The more often it is installed, the more a consistently high standard of breast care will be achieved. But we are not complacent. We are constantly innovating and looking at ways of improving Transpara still further.

We will continue to do all we can to facilitate earlier detection and treatment and to give women with breast cancer a much better chance of a cure.